Tuesday, April 29, 2025

Latest

Mindcure Ends Fiscal Q1 2022 With $15.6 Million Cash & Cash Equivalents, $2.8 Million Net Loss

Mind Cure Health (CSE: MCUR) announced on Tuesday the financial results for the three months ended August 31, 2021. The firm ended the quarter with a $2.8 million net loss compared to fiscal Q1 2021’s net loss of $0.3 million.

Among the company’s expenses for the quarter include $1.0 million in consulting fees and payroll, $0.2 million worth of inventory write down, and $0.3 million in share-based payments. The quarterly loss translates to $0.03 per share.

On the other hand, the firm ended the quarter with a cash and cash equivalents balance of $15.6 million. This makes the current assets worth $16.4 million while the current liabilities came in at $1.3 million.

The firm also relayed that it has granted a total of 70,000 stock options to certain employees related to its long-term incentive plan.

Mind Cure Health last traded at $0.29 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Mind Cure Closes $3.6 Million Oversubscribed Financing

Mind Cure Health (CSE: MCUR) reported midday today that it has closed its non-brokered private...

Thursday, November 19, 2020, 04:28:12 PM

Mind Cure Sees Warrants Approved For Trading

Mind Cure Health (CSE: MCUR) is looking to provide a boost to its liquidity for...

Thursday, February 11, 2021, 09:32:23 AM

Mind Cure Set To Launch Products Into Psychedelic Therapy Adaptogen Supplement Category

Mind Cure Health (CSE: MCUR) has completed the development of its first products. The company...

Tuesday, January 26, 2021, 08:43:59 AM

Mind Cure Doubles Bought Deal Financing To $20 Million

Strong demand continues within the psychedelics space, with Mind Cure Health (CSE: MCUR) announcing earlier...

Friday, January 22, 2021, 02:07:33 PM

Mind Cure Announces New Product, Launch Dates For Nootropic Products

Mind Cure Health (CSE: MCUR) this morning announced that it intends to bring a new...

Tuesday, December 29, 2020, 07:14:06 AM